Ayman Tourbah

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 508 citations · Full text

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Ayman Tourbah, Christine Lebrun‐Frénay, Gilles Edan et al. · Multiple Sclerosis Journal · 2016 · 284 citations · Full text

High doses of biotin in chronic progressive multiple sclerosis: A pilot study

Frédéric Sedel, Caroline Papeix, Agnès Bellanger et al. · Multiple Sclerosis and Related Disorders · 2015 · 219 citations · Full text

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

Caroline Papeix, Jean‐Sébastien Vidal, J. de Sèze et al. · Multiple Sclerosis Journal · 2007 · 204 citations

Clinical Immunology, Ocular Disease, Neurological Disorder +21

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5